ArticleExperimental brain research2026
Levodopa-induced alterations in vertical center of mass and muscle synergy structure during Parkinsonian gait.
Article in Experimental brain research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Parkinson's disease (PD) is a neurodegenerative disorder characterized by gait impairments that affect the regulation of whole-body movement, which can be quantified through metrics such as vertical center of mass (vCoM). In healthy gait, vCoM oscillations contribute to metabolic efficiency by facilitating the exchange between kinetic and potential energy; however, this mechanism is often disrupted in PD. Although levodopa improves motor impairments, its impact on vCoM and neuromuscular control remains poorly understood. This study investigated levodopa effects on vCoM and neuromuscular coordination in fifteen patients with PD (Hoehn & Yahr 2-3) during PD OFF (before levodopa) and PD ON (after levodopa) and compared to nine healthy older adults (HOA). Kinematic and electromyography data were collected during an overground walk to quantify vCoM and muscle synergies. Here we show that levodopa significantly increased maximum vCoM displacement (p = 0.002), with PD OFF showing significantly reduced displacement compared to HOA (p < 0.001) while PD ON did not differ significantly, indicating a shift in vCoM displacement towards healthy patterns. Temporal patterns of muscle synergies showed that PD OFF exhibited prolonged activation duration and slower slope-to-peak in Synergy 2 (push-off) compared to HOA while spatial patterns of Synergy 2 showed an increase in gastrocnemius muscle contribution in PD ON compared to PD OFF (p = 0.002). Together these findings demonstrate that levodopa might partially restore whole-body gait mechanics through a unique reorganization of muscle synergy structure, pointing to a possible functional link between neuromuscular coordination and gait dynamics in PD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.